NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE166749 Query DataSets for GSE166749
Status Public on Aug 03, 2022
Title APE1 controls DICER1 expression through functional regulation of miRNA33a and miRNA130b: a novel hypothesis for NSCLC cancer progression [NanoString]
Organism Homo sapiens
Experiment type Non-coding RNA profiling by array
Summary Lung cancer is the leading cause of cancer death worldwide. The lack of specific and sensitive methods for early diagnosis as well as inadequate targeted therapies contribute to poor outcomes. A growing body of evidences suggests different roles of microRNAs including development and progression of lung cancer. The overexpression of the DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1) is an important cause of poor chemotherapeutic and its expression is able to predict the progression-free and overall survival in patients receiving platinum-containing chemotherapy. Recently, we have demonstrated APE1 involvement in miRNA biogenesis related to cancer progression. In this article, we report the identification of miRNAs that are modulated in lung cancer cells upon APE1 silencing. We defined a miRNA signature consisting of the 13 miRNAs, which strongly correlates with APE1 expression in lung cancer: miR-1246, miR-4488, miR-24, miR-183, miR-660, miR-130b, miR-543, miR-200c, miR-376c, miR-218, miR-146a, miR-92b and miR-33a. Gene ontology annotation and pathway analysis of the miRNA signature revealed its biological significance in cancer proliferation and survival. Among the miRNAs downregulated by APE1 is miRNA-33a-5p which targets Dicer, a major miRNA biogenesis gene whose expression is found to be downregulated in several tumours. We here validated Dicer as a direct functional target of miR-33a and profiled miR-33a, DICER and APE1 expression in clinical samples. Our findings suggest that APE1 may promote lung cancer progression through modulation of Dicer expression via miR-33a regulation. Our findings reveal new mechanistic insight into how APE1 functions in tumor biology.
 
Overall design In the study presented here, miRNA expression profiling was performed with 100 ng of total RNAs from A549 silenced for APE1–protein expression. The experiment was performed in triplicates.
 
Contributor(s) Antoniali G, Dalla E, Mangiapane G, Zhao X, Cheng Y, De Sanctis V, Ayyildiz D, Piazza S, Li M, Tell G
Citation(s) 35876890
Submission date Feb 15, 2021
Last update date Aug 04, 2022
Contact name Silvano Piazza
E-mail(s) silvano.piazza@icgeb.org
Organization name ICGEB
Lab Computational Biology
Street address localita' Padriciano 99
City Trieste
ZIP/Postal code 34149
Country Italy
 
Platforms (1)
GPL28943 NanoString nCounter Human v3 miRNA Expression Assay
Samples (6)
GSM5082113 A549 cells transiently transfected with 100 pmol scramble control siRNA, replicate 1
GSM5082114 A549 cells transiently transfected with 100 pmol scramble control siRNA, replicate 2
GSM5082115 A549 cells transiently transfected with 100 pmol scramble control siRNA, replicate 3
This SubSeries is part of SuperSeries:
GSE166750 APE1 controls DICER expression through functional regulation of miRNA33a: a novel hypothesis for NSCLC cancer progression
Relations
BioProject PRJNA701901

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE166749_RAW.tar 50.0 Kb (http)(custom) TAR (of TXT)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap